Apax Partners buys Invent Farma for €220m

As part of the deal, Apax acquired its stake from a syndicate of existing shareholders, including the company's chair Friðrik Steinn Kristjánsson and Horn II, a private equity fund managed by investment company Landsbref.

The company is keen on using the capital injection to expand internationally and pursue several strategic acquisitions in the pharma sector.

The transaction follows the GP's investment in German competitor Neuraxpharm in July 2016.

Company
Founded in 2004, Invent Farma develops and manufactures generic drugs for the pharmaceuticals industry.

Headquartered in Barcelona, the company owns three operating plants in Spain and posted a turnover of €83.5m in 2014, employing 430 people.

People
Apax Partners – Steven Dyson (partner, co-head of healthcare).
Invent Farma – Friðrik Steinn Kristjánsson (chair); Ervin Veszpremi (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Healthcare
• Southern Europe
• Spain
• Apax Partners